Search

Search Constraints

You searched for: Author/Creator Harkin, Andrea

Search Results

1. SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. Issue 11 (27th November 2018)

2. Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer. (14th January 2019)

3. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Issue 36 (20th December 2021)

4. Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. Issue 1 (28th November 2020)

5. Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer. Issue 6 (20th February 2021)

6. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Issue 12 (December 2020)

7. Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer. (13th May 2020)